carmofur has been researched along with niclosamide in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Easwaran, M; Manickam, M; Pillaiyar, T; Wendt, LL | 1 |
| Chen, J; Gao, K; Huang, F; Tepe, JJ; Wang, R; Wei, GW | 1 |
| Abercrombie, JJ; Leung, KP; Lopez-Ribot, JL; Ramasubramanian, AK; Srinivasan, A; Torres, NS | 1 |
1 review(s) available for carmofur and niclosamide
| Article | Year |
|---|---|
The recent outbreaks of human coronaviruses: A medicinal chemistry perspective.
Topics: Antiviral Agents; Chemistry, Pharmaceutical; COVID-19; Disease Outbreaks; Drug Repositioning; Humans; Virus Internalization | 2021 |
2 other study(ies) available for carmofur and niclosamide
| Article | Year |
|---|---|
Perspectives on SARS-CoV-2 Main Protease Inhibitors.
Topics: Antiviral Agents; Coronavirus 3C Proteases; Humans; Protease Inhibitors | 2021 |
Screening a Commercial Library of Pharmacologically Active Small Molecules against Staphylococcus aureus Biofilms.
Topics: Anti-Bacterial Agents; Auranofin; Biofilms; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Repositioning; Fluorouracil; High-Throughput Screening Assays; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Niclosamide; Small Molecule Libraries; Staphylococcus aureus | 2016 |